Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
0
There is no goods in the shopping cart !
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > Coagulation factor X

Coagulation factor X

Brief Information

Name:Coagulation factor X
Target Synonym:EC 3.4.21,EC:3.4.21.6,Stuart factor,Coagulation factor X,F10,Stuart-Prower Factor,Prothrombinase,EC 3.4.21.6,Factor Xa,Factor X,FXA,FX
Number of Launched Drugs:108
Number of Drugs in Clinical Trials:56
Lastest Research Phase:Approved

Product ListCompare or Buy

By Product Status:
By Product Category:
By Species:
By Tag:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
F10-C52H9 Cynomolgus Cynomolgus Coagulation factor X / F10 Protein, His Tag (MALS verified)
F10-C52H9-structure
F10-C52H9-sds
ACRO Quality

Part of Bioactivity data

F10-C52H9-MALS-HPLC
Coagulation factor X MALS images

The purity of Cynomolgus Coagulation factor X, His Tag (Cat. No. F10-C52H9) is more than 90% and the molecular weight of this protein is around 52-70 kDa verified by SEC-MALS.

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Human prothrombin complex (Hualan Biological Engineering) Approved Hualan Genetic Engineering Co Ltd Mainland China Blood Coagulation Disorders; Factor X Deficiency Hualan Biological Engineering Inc 1999-01-01 Blood Coagulation Disorders; Hemophilia B; Factor X Deficiency Details
Human Coagulation Factor VIII (Hemarus Therapeutics) Approved Hemarus Therapeutics CLOTATE India Hemophilia A Hemarus Therapeutics 2015-08-01 Hemophilia A Details
Human Coagulation Factor IX (Hemarus Therapeutics) Approved Hemarus Therapeutics Clotnine India Hemophilia B Hemarus Therapeutics 2015-08-01 Hemophilia B Details
Factor VIII (Intas Pharmaceuticals) Approved Intas Biopharmaceuticals Factocel VIII Hemophilia A Details
Antihemophilic Factor (Recombinant) Approved Baxalta Incorporated Recombinate United States Hemophilia A null 1992-12-10 Hemophilia A Details
Dalteparin Sodium FR-860; KV-165; KABI-2165 Approved Pfizer Pharmaceuticals Ltd (China) 法安明, Fragmin Germany Thrombosis Pfizer Inc 1985-01-01 Brain Neoplasms; Low Back Pain; Anemia, Sickle Cell; Thrombosis; Kidney Failure, Chronic; Thrombophilia; Lung Neoplasms; Venous Thrombosis; Colorectal Neoplasms; Pregnancy Complications; Breast Neoplasms; Hepatic Veno-Occlusive Disease; Prostatic Neoplasms; Atrial Fibrillation; Diabetic Foot; Abortion, Habitual; Central Nervous System Neoplasms; Thromboembolism; Stroke; Coronary Artery Disease; Neoplasms; Brain Injuries, Traumatic; Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Ovarian Neoplasms; Pulmonary Embolism Details
Rivaroxaban JNJ-39039039; BAY-59-7939; YHP-1807; YHR-1901 Approved Bayer AG Xarelto, 拜瑞妥 Canada Atherosclerosis Bayer AG 2008-09-15 Obesity; Antiphospholipid Syndrome; Embolism and Thrombosis; Atrial Fibrillation; Coronary Disease; Rheumatic Diseases; Cardiovascular Diseases; Rheumatic Heart Disease; Urologic Neoplasms; Osteoarthritis, Knee; Venous Thrombosis; Renal Insufficiency, Chronic; Acute Coronary Syndrome; Arthritis; Thrombocytopenia; Intraoperative Complications; Peripheral Arterial Disease; Respiratory Insufficiency; Kidney Failure, Chronic; Thrombosis; Osteoarthritis, Hip; Heart Defects, Congenital; Anemia, Sickle Cell; Diabetes Mellitus, Type 2; Embolism; Myocardial Ischemia; Upper Extremity Deep Vein Thrombosis; Venous Thromboembolism; Heart Failure; Communicable Diseases; Myocardial Infarction; Angina, Unstable; Atherosclerosis; Mitral Valve Stenosis; Pulmonary Embolism; Coronary Artery Disease; Kidney Diseases; Coronavirus Disease 2019 (COVID-19); Neoplasms; Obesity, Morbid; Retinal Artery Occlusion; beta-Thalassemia; Stroke; Thromboembolism; Hemorrhage Details
Von Willebrand factor/coagulation factor VIII complex (human, Octapharma) Approved Octapharma Eqwilate, Wilnativ, Wilate Germany Hemophilia A; von Willebrand Diseases Octapharma 2005-01-01 von Willebrand Diseases; Hemophilia A Details
Eftrenonacog Alfa BIIB-029; FIX:Fc; FIXFc; rFIXFc Approved Sobi, Biogen Inc, Bioverativ Inc Alprolix, 赛玖凝 United States Hemophilia B null 2014-03-28 Hemophilia B Details
Human Coagulation Factor Ⅷ (Guangdong Shuanglin Bio-Pharmaceutical) Approved Guangdong Shuanglin Bio-Pharmaceutical Co Ltd Mainland China Hemophilia A Guangdong Shuanglin Bio-Pharmaceutical Co Ltd 2020-06-17 Hemophilia A Details
Antithrombin III (CSL Behring) BI51.017 Approved Csl Behring Llc Kybernin, Anthrobin, Athimbin Japan Thrombosis; Disseminated Intravascular Coagulation Csl Behring Llc 1987-08-02 Disseminated Intravascular Coagulation; Thrombosis Details
Human prothrombin complex (Sinopharm Shanghai Plasma) Approved Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd Mainland China Hemorrhage Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd 1997-01-01 Hemorrhage Details
Efmoroctocog alfa BIIB-031; rFVIIIFc Approved Biogen Inc, Sobi, Bioverativ Inc Elocta, Eloctate United States Hemophilia A null 2014-06-06 Hemophilia A Details
Nonacog alfa rh-F-IX; rh-Factor-IX Approved Pfizer Pharmaceuticals Ltd (China) 贝赋, BeneFIX EU Hemophilia B Pfizer Europe Ma Eeig 1997-08-27 Hemophilia B Details
Human prothrombin complex (Nanyue Biopharming) Approved Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd Mainland China Hemorrhage Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd 2019-09-05 Hemophilia B; Hemorrhage Details
Eptacog beta LR-769; rhFVIIa Approved Lfb Biotechnologies Sas, Revo Biologics Inc Sevenfact United States Hemophilia A; Hemophilia B Lfb Biotechnologies Sas 2020-04-01 Hemophilia A; Hemophilia B Details
Recombinant Human Coagulation Factor VIII (sinocelltech) SCT-800 Approved SinoCelltech Ltd Mainland China Hemophilia A SinoCelltech Ltd 2021-07-20 Hemophilia A; Blood Loss, Surgical Details
Polysulfonic mucopolysaccharide M-118102; M-1180B; M-7040B Approved Maruho Co Ltd 喜辽妥, 喜疗妥 Japan Chilblains; Cicatrix; Arthritis; Thrombophlebitis Maruho Co Ltd 1954-10-01 Phlebitis; Thrombophlebitis; Chilblains; Contusions; Cicatrix; Arthritis Details
Octocog alfa BAY14-2222 Approved Bayer AG Kogenate, Helixate NexGen, Kovaltry, Iblias, Kogenate/Kovaltry, 科跃奇 United States Hemophilia A Bayer Healthcare 1993-02-25 Blood Coagulation Disorders; Hemophilia A Details
Apixaban BMS-562247-01; BMS-562247; TAH-3311 Approved Bristol-Myers Squibb Company Eliquis, 艾乐妥, 艾乐通 EU Venous Thromboembolism Bristol-Myers Squibb/Pfizer Eeig 2011-05-18 Renal Insufficiency, Chronic; Glomerulonephritis, Membranous; Atrial Fibrillation; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Ischemic Attack, Transient; Cardiovascular Diseases; Genital Neoplasms, Female; Aortic Valve Insufficiency; Primary Myelofibrosis; Colitis, Ulcerative; Astrocytoma; Venous Thrombosis; Thromboembolism; Lymphoma; Aortic Valve Stenosis; Thrombocytopenia; Nephrotic Syndrome; Thrombosis; Kidney Failure, Chronic; Anemia, Sickle Cell; Rectal Diseases; Crohn Disease; Thrombocythemia, Essential; Fasting; Inflammatory Bowel Diseases; Rejection of renal transplantation; Hematologic Neoplasms; Solid tumours; Embolism; Bone Marrow Neoplasms; Venous Thromboembolism; Cerebral Hemorrhage; Death; Foramen Ovale, Patent; Polycythemia Vera; Spinal Cord Injuries; Pulmonary Embolism; Atrial Flutter; Neoplasms; Coronavirus Disease 2019 (COVID-19); Aortic valve diseases; Proteinuria; Myeloproliferative Disorders; Pancreatic Neoplasms; Glioblastoma; Acute Coronary Syndrome; Stroke; Hemorrhage Details
Factor XP Behring (CSL Behring) Approved Csl Behring Llc Spain Factor X Deficiency Csl Behring Llc 2015-09-01 Factor X Deficiency Details
Eptacog alfa biosimilar (AryoGen Biopharma) Approved Aryogen Biopharma Iran Factor VII Deficiency; Hemophilia A; Hemophilia B; Thrombasthenia Aryogen Biopharma 2014-01-01 Hemophilia A; Hemophilia B; Factor VII Deficiency; Thrombasthenia Details
Prothrombinex-VF (CSL Behring) Approved Csl Behring Llc Australia Hemorrhage Csl Behring Llc 2014-10-01 Hemorrhage Details
Trenonacog alfa IB-1001; APVO-101 Approved Inspiration Biopharmaceuticals Ixinity United States Hemophilia B null 2015-05-14 Hemophilia B Details
Antihemophilic factor/von Willebrand factor (CSL Behring) Approved Csl Behring Llc Aleviate, Biostate, Humate-P, Voncento United States von Willebrand Diseases; Hemophilia A null 1999-04-01 von Willebrand Diseases; Hemophilia A Details
Moroctocog alfa biosimilar (International Biotech Center Generium) GNR-002 Approved International Biotech Center Generium Octofactor Russian Federation Hemophilia A International Biotech Center Generium 2013-01-01 Hemophilia A Details
Antithrombin III (Octapharma Ab) Approved Octapharma Ab Atenativ EU Antithrombin III Deficiency Octapharma Ab 2007-12-20 Antithrombin III Deficiency Details
Human prothrombin complex (Shanghai Xinxing) Approved Shanghai Xinxing Medicine Co Ltd Mainland China Hemorrhage Shanghai Xinxing Medicine Co Ltd 1997-01-01 Hemorrhage Details
Human prothrombin complex (Guangdong Wellen) Approved Guangdong Wellen Pharmaceutical Co Ltd Mainland China Hemorrhage Guangdong Wellen Pharmaceutical Co Ltd 2020-10-21 Hemophilia B; Hemorrhage Details
Human coagulation factor Ⅷ (Shandong Taibang) Approved Shandong Taibang Biological Products Co Ltd Mainland China Shandong Taibang Biological Products Co Ltd 2012-06-15 Details
Rurioctocog alfa pegol BAX-0855; BAX-855; TAK-660 Approved Baxalta Incorporated, Nektar Therapeutics Adynovi, Adynovate United States Hemophilia A null 2015-11-13 Hemophilia A Details
Susoctocog alfa BAX-802; BAX-801; TAK-672; SHP-672; OBI-1 Approved Baxalta Incorporated Obizur United States Hemophilia A null 2014-10-23 Hemophilia A; Hemorrhage; Acquired hemophilia Details
Efanesoctocog alfa BIVV-001; BIVV001 Approved Amunix Pharmaceuticals Inc, Bioverativ Inc Altuviiio United States Hemophilia A Sanofi 2023-02-23 von Willebrand Diseases; Hemophilia A Details
Edoxaban Tosilate Hydrate DU-176b Approved Daiichi Sankyo Co Ltd Savaysa, 里先安, Roteas, Lixiana, Lixiana/Savaysa Japan Venous Thromboembolism; Venous Thrombosis; Stroke; Embolism; Pulmonary Embolism Daiichi Sankyo Co Ltd 2011-04-22 HIV Infections; Embolism; Pulmonary Embolism; Venous Thromboembolism; Neoplasms; Heart Diseases; Stroke; Thromboembolism; Embolism and Thrombosis; Atrial Fibrillation; Osteoarthritis, Knee; Inflammation; Venous Thrombosis; Aortic Valve Stenosis; Thrombosis Details
Human Coagulation Factor Ⅷ (Shanghai Raas Blood Products) Approved Shanghai Raas Blood Products Co Ltd Mainland China Hemophilia A Shanghai Raas Blood Products Co Ltd 1995-01-01 Hemophilia A Details
Enoxaparin sodium biosimilar (Chandra Bhagat Pharma) Approved Chandra Bhagat Pharma(Cbc) MAXIPARINE Venous Thrombosis Details
Human prothrombin complex (Tonrol Biopharmaceuticals) Approved Tonrol Bio-Pharmaceutical Co Ltd ProthoRAAS Mainland China Hemorrhage Shanghai Raas Blood Products Co Ltd 1996-01-01 Hemophilia B; Hemorrhage Details
Nonacog alfa (International Biotech Center Generium) GNR-003 Approved International Biotech Center Generium Innonafactor Russian Federation Hemophilia B International Biotech Center Generium 2014-01-01 Hemophilia B Details
Factor IX complex (Grifols) Approved Grifols Sa Profilnine United States Hemophilia B null 1981-07-21 Intracranial Hemorrhages; Hemophilia B Details
Moroctocog alfa biosimilar (Amega Biotech) Approved Amega Biotech Argentina Hemophilia A Amega Biotech 2012-01-01 Hemophilia A Details
Human prothrombin complex (Octapharma) Approved Octapharma Ocplex, Octaplex, Pronativ Germany Hemorrhage Octapharma 2003-03-14 Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma Details
Factor VIII biosimilar (Chia Tai-Tianqing) KN-008 Approved Suzhou Alphamab Co Ltd, Jiangsu Chia Tai-Tianqing Pharmaceutical Co Ltd 安恒吉 Mainland China Hemophilia A Nanjing Shunxin Pharmaceuticals Co Ltd Of Chiatai Tianqing Pharmaceutical Group 2023-08-29 Hemophilia A Details
Factor VIII (Tonrol Biopharmaceuticals) Hemorass Approved Tonrol Bio-Pharmaceutical Co Ltd HEMORAAS Hemophilia A Details
Freeze-dried activated human blood coagulation factor Ⅶ concentrate containing factor Ⅹ (Kaketsuken/KM Biologics) MC-710 Approved Kaketsuken Byclot Japan Hemophilia A null 2014-07-04 Hemophilia A Details
Human Coagulation Factor Ⅷ (Sinopharm Shanghai Plasma) Approved Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd Mainland China Hemophilia A Sinopharm Shanghai Plasma-Derived Biotherapies Co Ltd 2012-07-23 Hemophilia A Details
Human Coagulation Factor Ⅷ (Jiangxi Boya Bio-Pharmaceutical ) Approved Boya Bio-Pharmaceutical Group Co Ltd Mainland China Hemophilia A Boya Bio-Pharmaceutical Group Co Ltd 2022-08-08 Hemophilia A; Hemorrhage Details
Human Coagulation Factor IX(China Biologic Products) Approved Shandong Taibang Biological Products Co Ltd Mainland China Hemophilia B Shandong Taibang Biological Products Co Ltd 2020-07-08 Hemophilia B Details
Enoxaparin sodium biosimilar (Sahar International Trading) Approved Sahar International Trading Angina, Unstable; ST Elevation Myocardial Infarction; Venous Thromboembolism; Blood Coagulation Disorders Sahar International Trading 2013-07-01 Blood Coagulation Disorders; Angina, Unstable; ST Elevation Myocardial Infarction; Venous Thromboembolism Details
Ardeparin sodium Approved Wyeth-Ayerst Normiflo United States Pulmonary Embolism; Venous Thrombosis null 1997-05-01 Pulmonary Embolism; Venous Thrombosis Details
Antithrombin III (Human, Grifols) Approved Grifols Sa Thrombate III United States Thromboembolism; Antithrombin III Deficiency null 1991-12-30 Venous Thromboembolism; Liver Cirrhosis; Coronavirus Disease 2019 (COVID-19); Thromboembolism; Antithrombin III Deficiency; Postoperative Complications; Wounds and Injuries; Venous Thrombosis Details
Human coagulation factor Ⅷ (Shanghai Institute of Biological Products) Approved Shanghai Institute Of Biological Products Co Ltd Mainland China Hemophilia A; Hemorrhagic Disorders Shanghai Institute Of Biological Products Co Ltd 2012-07-23 Hemorrhagic Disorders; Hemophilia A Details
Nonacog gamma rFIX; BAX-326 Approved Baxalta Incorporated Rixubis United States Hemophilia B null 2013-06-26 Hemophilia B Details
Enoxaparin sodium biosimilar (Rovi) Approved Rovi Arovi Angina, Unstable; Myocardial Infarction; Venous Thrombosis Rovi 2018-03-31 Angina, Unstable; Myocardial Infarction; Venous Thrombosis Details
Turoctocog alfa pegol NN-7088; N8-GP; N8-GP-rFVIII; NNC-0129-0000-1003 Approved Novo Nordisk A/S Esperoct United States Hemophilia A Novo Nordisk Inc 2019-02-19 Hemophilia A; Hemorrhage Details
Beroctocog alfa GC-1101; GC-1101C Approved GC Biopharma Corp GreenGene F South Korea Hemophilia A GC Biopharma Corp 2009-12-01 Hemophilia A Details
Moroctocog alfa PF-05208756; r-VIII SQ; PF-5208756; r-Factor VIII SQ; BDDrFVIII Approved Pfizer Pharmaceuticals Ltd (China) ReFacto, Xyntha, Refacto AF, Xyntha Solofuse, Refacto AF/Xyntha, 任捷 EU Hemophilia A Pfizer Europe Ma Eeig 1999-04-13 Hemophilia A Details
Factor IX (Bio Products Laboratory) Approved Bio Products Laboratory Ltd Replenine-VF United Kingdom Hemophilia B Bio Products Laboratory Ltd 1999-08-09 Hemophilia B Details
Lonoctocog alfa CSL-627; NBP-601 Approved Csl Behring Llc, Sk Chemicals Afstyla United States Hemophilia A Csl Behring Ag 2016-05-25 Hemophilia A Details
Certoparin sodium Approved Novartis Pharma Ag Troparin, Alphaparin, Sandoparin, Sandoparine, Mono-Embolex Pulmonary Embolism; Thromboembolism; Venous Thrombosis null 1997-01-01 Pulmonary Embolism; Embolism; Renal Insufficiency; Thromboembolism; Uremia; Atrial Fibrillation; Venous Thrombosis; Kidney Failure, Chronic Details
Human prothrombin complex (CSL Behring) BE-1116 Approved Csl Behring Llc Kcentra, Beriplex, Confidex Blood Coagulation Disorders; Coagulation Protein Disorders; Heart Failure; Heart Diseases; Hemorrhage; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Wounds and Injuries Details
Human prothrombin complex concentrate (Guizhou Taibang Biological Products) Approved Guizhou Taibang Biological Products Co Ltd Mainland China Hypoprothrombinemias Guizhou Taibang Biological Products Co Ltd 2013-07-31 Hypoprothrombinemias Details
Fondaparinux Sodium GSK-576428; Org-31540; SR-90107; SR-90107A Approved Organon Arixtra, Quixidar, 安卓 United States Liver Diseases; Pulmonary Embolism; Venous Thrombosis Mylan Ireland Ltd 2001-12-07 Liver Diseases; Uterine Cervical Neoplasms; Endometrial Neoplasms; Venous Thrombosis; Fallopian Tube Neoplasms; Atrial Fibrillation; Vulvar Neoplasms; Sarcoma; Coronary Disease; Angina Pectoris; Pulmonary Embolism; Thromboembolism; Neoplasms; Obesity, Morbid; Renal Insufficiency; Vaginal Neoplasms; Venous Thromboembolism; Angina, Unstable; Myocardial Infarction; Ovarian Neoplasms Details
Human coagulation factor Ⅷ (Chengdu Rongsheng Pharmaceuticals) Approved Chengdu Rongsheng Pharmaceuticals Co Ltd Mainland China Hemophilia A Chengdu Rongsheng Pharmaceuticals Co Ltd 2001-01-01 Hemophilia A Details
Human Coagulation Factor Ⅷ(Tonrol Bio-Pharmaceutical ) Approved Tonrol Bio-Pharmaceutical Co Ltd Mainland China Hemophilia A Tonrol Bio-Pharmaceutical Co Ltd 2013-08-23 Hemophilia A Details
Danaparoid sodium KB-101; Org-10172 Approved Merck Sharp & Dohme Corp, Organon Orgaran, Lomoparan Netherlands Thrombocytopenia; Venous Thromboembolism null 1991-01-01 Venous Thromboembolism; Thrombocytopenia; Venous Thrombosis Details
Antihemophilic factor B (Armour) Approved Csl Behring Llc, Armour Pharma MonoFIX, Mononine Hemophilia B null 1993-05-01 Hemophilia B Details
Simoctocog alfa Factor VIII; Human-cl rhFVIII Approved Octapharma Vihuma, Nuwiq EU Hemophilia A Octapharma Ab 2014-07-22 Hemophilia A Details
Heparin sodium biosimilar (Blau Pharmaceuticals) Approved Blau Pharmaceuticals Hepamax-S Brazil Thrombosis Blau Pharmaceuticals 2012-08-01 Thrombosis Details
Damoctocog alfa pegol BAY-949027 Approved Bayer AG Jivi United States Hemophilia A Bayer Healthcare 2018-08-29 Hemophilia A; Hemorrhage Details
Enoxaparin sodium biosimilar (PT Kalbe) Approved Kalbe Farma Kalbenox Cambodia Angina, Unstable; Myocardial Infarction; Venous Thrombosis Kalbe Farma 2012-01-01 Angina, Unstable; Myocardial Infarction; Venous Thrombosis Details
Antihemophilic factor/von Willebrand factor complex (Human, Grifols Biologicals) Approved Grifols Sa Alphanate United States Hemophilia A; von Willebrand Diseases null 1978-08-15 von Willebrand Diseases; Hemophilia A Details
Eptacog alfa biosimilar (International Biotech Center Generium) GNR-001 Approved International Biotech Center Generium Russian Federation Hemophilia A International Biotech Center Generium 2015-01-01 Hemophilia A Details
Human prothrombin complex (LFB) Approved Lfb Biotechnologies Sas KANOKAD France Hemorrhage Lfb Biotechnologies Sas 2008-09-01 Hemorrhage Details
Enoxaparin sodium biosimilar (Harvest Moon Pharmaceuticals) Approved Harvest Moon Angina, Unstable; Myocardial Infarction; Venous Thromboembolism; Venous Thrombosis Details
Human Coagulation Factor Ⅷ (Hualan Biological Engineering) Approved Hualan Genetic Engineering Co Ltd 康斯平, Kangsiping Mainland China Blood Coagulation Disorders; Hemophilia A Hualan Biological Engineering Inc 2000-01-01 Blood Coagulation Disorders; Hemophilia A Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
Tearexaban TRx1 Phase 2 Clinical F. Hoffmann-La Roche Ltd Stroke; Venous Thrombosis Details
Zifaxaban TY-602 Phase 2 Clinical Tianjin Remedy Research Institute Pulmonary Embolism; Venous Thrombosis Details
Coagulation factor VIII (Hebei Daan Pharma) Phase 3 Clinical Hebei Daan Pharmaceutical Co Ltd Hemophilia A Details
Human prothrombin complex(Chengdu Rongsheng Pharmaceuticals) Phase 3 Clinical Chengdu Rongsheng Pharmaceuticals Co Ltd Hemophilia B Details
Human prothrombin complex concentrate (Harbin Shiheng Bioengineering Pharmaceutical) Phase 3 Clinical Harbin Pacific Biopharmaceutical Co Ltd Hemophilia B Details
Ciraparantag PER-977 Phase 2 Clinical Perosphere Inc Hemorrhagic Disorders Details
Factor VIII (CSL/Zhong Yuan Rui De Biological Products) Phase 3 Clinical Csl Ltd Hemophilia A Details
R-1663 R-1663 Phase 1 Clinical F. Hoffmann-La Roche Ltd Thrombosis Details
Marzeptacog alfa CB-813; CB-813d; PF-5280602; PF-05280602 Phase 1 Clinical Catalyst Hemophilia A; Hemophilia B Details
Mim8 Mim8; NN7769; NNC0365-3769; NN-7769 Phase 3 Clinical Novo Nordisk A/S Hemophilia A Details
Renaparin Phase 1 Clinical Vedanta Biosciences Inc Delayed Graft Function Details
Human coagulation factor Ⅷ /Human von Willebrand factor (Shandong Taibang Biological Products) Phase 3 Clinical Shandong Taibang Biological Products Co Ltd von Willebrand Diseases; von Willebrand Disease, Type 1; Hemophilia A; Acquired hemophilia Details
WA1-089 WA1-089 Phase 1 Clinical North China Pharmaceutical Company Ltd Venous Thromboembolism Details
PEG-Recombinant FVIII-Fc fusion protein (Furen Medicines) FRSW-117 Phase 3 Clinical Kaifeng Pharmaceutical (Group) Co Ltd Blood Coagulation Disorders; Hemophilia A Details
Factor IX (Guangdong Shuanglin Bio-Pharmaceutical) Phase 3 Clinical Guangdong Shuanglin Bio-Pharmaceutical Co Ltd Hemophilia B Details
Recombinant factor VIII (Saman daroo 8) Phase 3 Clinical Saman Daroo 8 Hemophilia A Details
Human prothrombin complex (Lanzhou Lansheng Blood Products) Phase 3 Clinical Lanzhou Lansheng Blood Products Co Ltd Hemophilia B Details
HR-17020 HR17020; HR-17020 Phase 1 Clinical Jiangsu Hengrui Medicine Co Ltd Venous Thromboembolism; Thromboembolism; Nephrotic Syndrome Details
Human prothrombin complex(Hunan Ziguang Huhan Nanyue Pharmaceutical) Phase 3 Clinical Hunan Ziguang Huhan Nanyue Pharmaceutical Co Ltd Hemophilia B Details
Coagulation factor X activators (Staidson) STSP-0601 Phase 2 Clinical Staidson(Beijing) Biopharmaceuticals Co Ltd Hemorrhagic Disorders; Hemophilia A; Hemophilia B; Hemorrhage; Blood Loss, Surgical Details
Enoxaparin sodium biosimilar (Fresenius Kabi) Fresenius Kabi Canada Ltd Details
NXT-007 NXT-007 Phase 2 Clinical Chugai Pharmaceutical Co Ltd Hemophilia A Details
Rivaroxaban (Bio-synectics) BS-112 Phase 1 Clinical Bio-Synectics Inc Pulmonary Embolism; Venous Thrombosis Details
GS001 GS-001 Clinical Institute Of Hematology & Blood Diseases Hospital Hemophilia A Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA

Leave a message